Remedy Announces Partnership with Australian Stroke Alliance

Another milestone for Remedy Robotics as we announce our strategic partnership with the Australian Stroke Alliance to accelerate deployment of the Remedy N1 System to hospitals across Australia.

The Stroke Alliance represents 40 different health bodies and some of the world’s preeminent stroke experts. We are incredibly proud that they have chosen Remedy as their exclusive robotics partner to transform access to stroke care.

Stroke outcomes around the world are determined by geography and access to care. Those who can access immediate endovascular intervention at a specialist metropolitan centre often walk home, while those who require transfer or miss out on care face death or lifelong disability.

Australia’s geography means that this problem is felt acutely - fewer than 3% of Australians living outside major cities have access to endovascular care for stroke, entrenching inequity for rural and Indigenous Australians. For many, the best case is being flown thousands of kilometres to another city to receive care outside of the timely treatment window.

Even in major cities, only a limited number of centres offer round-the-clock endovascular intervention, necessitating costly transfers and delays, which are particularly meaningful for stroke where every 20 minutes of treatment delay costs patients 3 months of disability-free life. The outcome of limited access to endovascular care is unnecessary death, disability and huge system costs.

Together with the Australian Stroke Alliance, Remedy Robotics will address these treatment gaps and dramatically expand access to gold-standard endovascular care. Our partnership will span clinical trials, regulatory approval and all the way to a nationwide rollout of our system with experienced doctors in metropolitan centres able to use the Remedy N1 System to deliver immediate endovascular intervention to patients wherever they are.

This partnership has the potential to save thousands of Australian stroke patients from death and disability, make treatment as available in Darwin as it is in Darlinghurst, and generate upwards of $3 billion in benefits for the Australian healthcare system for stroke alone.

You can read more in our full press release here and David Swan's thoughtful piece in The Age / Sydne Morning Herald

We are incredibly excited by the opportunity to accelerate access to our groundbreaking technology and to work with the Stroke Alliance in pursuit of our shared ambition of providing immediate, flawless endovascular care to every patient, regardless of geography.

‍